ID   PER-604
AC   CVCL_W990
DR   Wikidata; Q54947211
RX   PubMed=17117183;
CC   Doubling time: 181 hours (PubMed=17117183).
ST   Source(s): PubMed=17117183
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12,13
ST   D13S317: 11,12
ST   D16S539: 10,11
ST   D18S51: 11,12,17
ST   D19S433: 14,16.2
ST   D21S11: 30,31.2
ST   D2S1338: 24,25
ST   D3S1358: 15,17
ST   D5S818: 11
ST   D7S820: 8,11
ST   D8S1179: 12,13
ST   FGA: 20,21
ST   TH01: 6,9
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia
DI   ORDO; Orphanet_99861; Precursor T-cell acute lymphoblastic leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 21-03-23; Version: 6
//
RX   PubMed=17117183; DOI=10.1038/sj.bjc.6603447;
RA   Beesley A.H., Palmer M.-L., Ford J., Weller R.E., Cummings A.J.,
RA   Freitas J.R., Firth M.J., Perera K.U., de Klerk N.H., Kees U.R.;
RT   "Authenticity and drug resistance in a panel of acute lymphoblastic
RT   leukaemia cell lines.";
RL   Br. J. Cancer 95:1537-1544(2006).
//